The Biobased Market Expansion Act of 2025 aims to significantly enhance the federal government's recognition, procurement, and domestic production of biobased products by amending the Farm Security and Rural Investment Act of 2002. It mandates that federal procuring agencies annually increase their biobased-only contracts or the volume of biobased products purchased, while also establishing price preferences for these items. A key focus is promoting biobased products that are produced wholly or in part within the United States, thereby encouraging domestic manufacturing . To improve compliance and transparency, the bill requires procuring agencies to ensure staff complete training on biobased product purchasing and for the General Services Administration to update federal catalogs to clearly delineate eligible biobased products. The Office of Federal Procurement Policy will annually collect and verify agency compliance data , including reasons for any failures to meet procurement requirements. Furthermore, the Comptroller General is directed to conduct a comprehensive review within two years, assessing implementation, data adequacy, and recommending improvements to increase the procurement of U.S.-made biobased products.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.
Introduced in Senate
Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.
Agriculture and Food
Biobased Market Expansion Act of 2025
USA119th CongressS-2693| Senate
| Updated: 9/3/2025
The Biobased Market Expansion Act of 2025 aims to significantly enhance the federal government's recognition, procurement, and domestic production of biobased products by amending the Farm Security and Rural Investment Act of 2002. It mandates that federal procuring agencies annually increase their biobased-only contracts or the volume of biobased products purchased, while also establishing price preferences for these items. A key focus is promoting biobased products that are produced wholly or in part within the United States, thereby encouraging domestic manufacturing . To improve compliance and transparency, the bill requires procuring agencies to ensure staff complete training on biobased product purchasing and for the General Services Administration to update federal catalogs to clearly delineate eligible biobased products. The Office of Federal Procurement Policy will annually collect and verify agency compliance data , including reasons for any failures to meet procurement requirements. Furthermore, the Comptroller General is directed to conduct a comprehensive review within two years, assessing implementation, data adequacy, and recommending improvements to increase the procurement of U.S.-made biobased products.